XML 44 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2017
Stockholders' Equity Note [Abstract]  
Schedule of assumptions used in estimation of grant date fair value of RSUs
The Company recognizes compensation expenses on these RSUs based on estimated grant date fair value, with the following assumptions:
 
   
2014
   
2015
 
Expected dividend yield
   
2.06
%
   
3.22
%
Termination rate
   
4.35
%
   
0
%
Schedule of assumptions used in estimation of grant date fair value of options
2.
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
 
Average Risk-free interest rate (a)
   
2.08
%
Expected dividend yield
   
2.09
%
Average expected volatility  (b)
   
53.01
%
Termination rate
   
9
%
Suboptimal factor(c)
   
3.4
 
 
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
 
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
 
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
 
2.
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
 
Average Risk-free interest rate (a)
   
1.58
%
Expected dividend yield
   
2.42
%
Average expected volatility  (b)
   
47.90
%
Termination rate
   
9
%
Suboptimal factor(c)
   
3.32
 
 
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
 
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
 
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
 
 
2.
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
 
Average Risk-free interest rate (a)
   
2.35
%
Expected dividend yield
   
2.42
%
Average expected volatility  (b)
   
43.71
%
Termination rate
   
9
%
Suboptimal factor (c)
   
3.28
 
 
 
(a)
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
 
(b)
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
 
(c)
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
 
 
3.
The Company recognizes compensation expenses on these RSUs based on estimated grant date fair value, with the following assumptions:
 
Expected dividend yield
   
2.68
%
Termination rate
   
1.74
%
Stock Option Summary
The following table summarizes information regarding stock options as at December 31, 2017:
 
 
   
Options outstanding
 
Options exercisable
 
       
Weighted average
     
Weighted average
 
       
remaining
     
remaining
 
Exercise price
 
Number
 
contractual life
 
Number
 
contractual life
 
US$
 
of options
 
(in years)
 
of options
 
(in years)
 
                   
15.28
     
7,825
     
2.7
     
7,825
     
2.7
 
                                   
26.91
     
19,582
     
5.6
     
19,582
     
5.6
 
                                   
33.27
     
19,706
     
8.3
     
13,137
     
8.3
 
                                   
28.38
     
88,124
     
6.4
     
-
     
-
 
                                   
39.62
     
114,674
     
7.1
     
-
     
-
 
                                   
       
249,911
             
40,544
         
Stock Option Activity
The stock option activity under the abovementioned plans is as follows:
   
 
               
Weighted
 
         
Weighted
   
average
 
   
Number
   
average
   
grant date
 
   
of options
   
exercise price
   
fair value
 
         
US$
   
US$
 
                   
Balance at January 1, 2015
   
192,130
             
                     
Granted
   
89,907
     
26.91
     
10.04
 
Exercised
   
(61,711
)
   
15.28
     
6.54
 
Forfeited
   
(5,625
)
   
24.07
     
9.19
 
                         
Balance at December 31, 2015
   
214,701
                 
                         
Granted*
   
116,455
     
29.34
     
10.96
 
Exercised
   
(62,269
)
   
15.28
     
6.54
 
Forfeited
   
(2,882
)
   
29.71
     
11.79
 
                         
Balance at December 31, 2016
   
266,005
                 
                         
Granted
   
119,925
     
39.62
     
11.89
 
Exercised
   
(124,918
)
   
21.46
     
8.46
 
Forfeited
   
(11,101
)
   
33.18
     
10.87
 
                         
Balance at December 31, 2017
   
249,911
                 
Exercisable at December 31, 2017
   
40,544
                 
 
*
 
In 2016 the Company granted in the aggregate, 116,455 options. Regarding the grant of 93,660 options, see Note 11E. Regarding the grant of 22,795 options, see Note 3B.
Schedule of Restricted Share Units activity
The Restricted Share Units activity under the abovementioned plans is as follows:
                 
 
         
Weighted
 
   
Number of
   
average
 
   
Restricted
   
grant date
 
   
Share Units
   
fair value
 
   
US$
   
US$
 
             
Balance at January 1, 2015
   
74,000
       
               
Granted
   
8,000
     
29.09
 
Vested
   
(4,000
)
   
46.07
 
                 
Balance at  December 31, 2015
   
78,000
         
                 
Vested
   
(35,000
)
   
46.54
 
                 
Balance at  December 31, 2016
   
43,000
         
                 
Granted
   
78,000
     
34.90
 
Vested
   
(43,000
)
   
42.52
 
                 
Balance at December 31, 2017
   
78,000
         
Summary of Allocation of the Stock-Based Compensation Expenses
During 2015, 2016 and 2017, the Company recorded share-based compensation expenses. The following summarizes the allocation of the stock-based compensation expenses:
 
   
Year ended December 31
 
   
2015
   
2016
   
2017
 
   
US$ thousands
   
US$ thousands
   
US$ thousands
 
                   
Cost of sales
   
150
     
180
     
320
 
Research and development costs
   
455
     
504
     
832
 
Selling and marketing expenses
   
502
     
366
     
537
 
General and administrative expenses
   
806
     
500
     
736
 
                         
     
1,913
     
1,550
     
2,425